Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003509035 | SCV004298055 | pathogenic | Inherited glutathione synthetase deficiency | 2023-09-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg418*) in the GSS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GSS are known to be pathogenic (PMID: 12638941, 15717202). This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with glutathione synthetase deficiency (PMID: 25851806). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005030120 | SCV005661804 | likely pathogenic | Glutathione synthetase deficiency without 5-oxoprolinuria; Glutathione synthetase deficiency with 5-oxoprolinuria | 2024-06-07 | criteria provided, single submitter | clinical testing |